Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2219197318', 'doi': None, 'title': 'S-1+Gemcitabine 併用化学療法が著効し長期生存中の進行膵癌術後肝転移の1 例', 'display_name': 'S-1+Gemcitabine 併用化学療法が著効し長期生存中の進行膵癌術後肝転移の1 例', 'publication_year': 2009, 'publication_date': '2009-01-01', 'ids': {'openalex': 'https://openalex.org/W2219197318', 'mag': '2219197318'}, 'language': 'ja', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.pieronline.jp/content/article/0385-0684/36120/2419', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306555422', 'display_name': '癌と化学療法', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5019741457', 'display_name': '星野宏光', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '星野宏光', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5058484638', 'display_name': 'ほか', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'ほか', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '36', 'issue': '12', 'first_page': '2419', 'last_page': '2421'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11067', 'display_name': 'Advancements in Colorectal Cancer Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11067', 'display_name': 'Advancements in Colorectal Cancer Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10073', 'display_name': 'Hepatocellular Carcinoma', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/treatment', 'display_name': 'Treatment', 'score': 0.499229}], 'concepts': [{'id': 'https://openalex.org/C2780258809', 'wikidata': 'https://www.wikidata.org/wiki/Q414143', 'display_name': 'Gemcitabine', 'level': 3, 'score': 0.9955689}, {'id': 'https://openalex.org/C2777844706', 'wikidata': 'https://www.wikidata.org/wiki/Q422504', 'display_name': 'Deoxycytidine', 'level': 4, 'score': 0.5286477}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.44770646}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.39159724}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.37619781}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.3146878}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.pieronline.jp/content/article/0385-0684/36120/2419', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306555422', 'display_name': '癌と化学療法', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'再発・進行膵癌における化学療法は,gemcitabine': [0], '単独療法が標準治療であるが,S-1+gemcitabine': [1], '併用化学療法も第II相試験で良好な成績が報告されつつある。今回,S-1+gemcitabine': [2], '併用化学療法が著効し,長期生存中の進行膵癌術後肝転移の1': [3], '例を経験したので報告する。症例は59': [4], '歳(手術時),女性。膵頭部癌,cT4N0M0,stageIVa': [5], 'との診断で術前化学放射線療法(gemcitabine': [6], '800': [7], 'mg/m2+RT': [8], '36': [9], 'Gy)を施行後,2005': [10], '年11': [11], '月に膵頭十二指腸切除術を施行した。術後病理組織診断はpoorly': [12], 'differentiated': [13], 'adenocarcinoma,pT4N0M0,StageIVa': [14], 'であった。術後外来経過観察中であったが,2006': [15], '年10': [16], '月,肝S8/7': [17], 'に径1': [18], 'cm': [19], '大,単発の肝転移を認め,S-1+gemcitabine': [20], '併用化学療法を35': [21], 'コース施行し(21': [22], 'days/1': [23], 'コース,S-180': [24], 'mg/m2': [25, 29], 'day': [26, 30], '1〜5,8〜12。gemcitabine': [27], '1,000': [28], '6,day': [31], '13),CR': [32], 'を得た。本症例においてS-1+gemcitabine': [33], '併用化学療法は,QOL': [34], 'を損なうことなく2': [35], '年もの長期の間安全に施行でき,肝転移のcontrol': [36], 'も良好であった。再発膵癌に対する化学療法は,術前にgemcitabine': [37], 'を用いた場合,薬剤耐性を考慮しS-1': [38], 'との併用療法も有効である可能性が示唆された。': [39]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2219197318', 'counts_by_year': [], 'updated_date': '2024-09-16T15:32:49.600829', 'created_date': '2016-06-24'}